5AM Venture Management »

Maplight Therapeutics shares owned by 5AM Venture Management

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by 5AM Venture Management from 13F filings

Historical chart of 5AM Venture Management investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by 5AM Venture Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $17M 950k 17.57

More positions owned by 5AM Venture Management

Entrada Therapeutics (TRDA)
Camp4 Therapeutics Corp (CAMP)
Tyra Biosciences (TYRA)
Miragen Therapeutics (VRDN)
Pharvaris N V (PHVS)
Erasca (ERAS)
Eyepoint Com New (EYPT)
Maplight Therapeutics (MPLT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Celldex Therapeutics Com New (CLDX)
Tectonic Therapeutic (TECX)
Enliven Therapeutics (ELVN)
Artiva Biotherapeutics (ARTV)
Surrozen Com New (SRZN)
Biohaven (BHVN)

View all positions for 5AM Venture Management

Top funds holding Maplight Therapeutics

Novo A/S
T. Rowe Price Investment Management
Goldman Sachs Group
Nan Fung Group Holdings
5AM Venture Management
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Geode Capital Management
Blue Owl Capital Holdings
State Street Corporation
Lazard Asset Management
Board of Trustees of The Leland Stanford Junior University
Freestone Grove Partners
Polygon Management
Bnp Paribas Investment Partners

View all funds holding Maplight Therapeutics